Enavate Sciences GP, LLC Long-Term Concentrated

CIK: 0001953107 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $327,524 (100.0% shares, 0.0% debt)

Holdings (7)

ZBIO ZENAS BIOPHARMA INC 25.5%

Value ($000) $83,502 Shares 3,761,359 Est. Cost $15.60 Unrealized +4.4%

SION SIONNA THERAPEUTICS INC 22.3%

Value ($000) $72,879 Shares 2,478,030 Est. Cost $16.34 Unrealized +33.1%

IMNM IMMUNOME INC 17.0%

Value ($000) $55,840 Shares 4,768,583 Est. Cost $11.41 Unrealized -12.8%

UPB UPSTREAM BIO INC 14.1%

Value ($000) $46,267 Shares 2,459,703 Est. Cost $22.33 Unrealized -30.4%

BBOT BRIDGEBIO ONCOLOGY THERAPEUT 9.3%

Value ($000) $30,420 Shares 2,626,946 Est. Cost $11.58 Unrealized —

CMPX COMPASS THERAPEUTICS INC 8.3%

Value ($000) $27,259 Shares 7,788,150 Est. Cost $1.66 Unrealized +90.2%

CAMP CAMP4 THERAPEUTICS CORP 3.5%

Value ($000) $11,357 Shares 3,785,802 Est. Cost $8.22 Unrealized -77.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ZBIO	ZENAS BIOPHARMA INC	3,761,359	$83,502	25.5%	$15.60	+4.4%	COM	98937L105
SION	SIONNA THERAPEUTICS INC	2,478,030	$72,879	22.3%	$16.34	+33.1%	COM	829401108
IMNM	IMMUNOME INC	4,768,583	$55,840	17.0%	$11.41	-12.8%	COM	45257U108
UPB	UPSTREAM BIO INC	2,459,703	$46,267	14.1%	$22.33	-30.4%	COM	91678A107
BBOT	BRIDGEBIO ONCOLOGY THERAPEUT	2,626,946	$30,420	9.3%	$11.58	—	COM NEW	107924102
CMPX	COMPASS THERAPEUTICS INC	7,788,150	$27,259	8.3%	$1.66	+90.2%	COM	20454B104
CAMP	CAMP4 THERAPEUTICS CORP	3,785,802	$11,357	3.5%	$8.22	-77.5%	COM	13463J101